Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

SB 590885, Tocris Bioscience™

Catalog No. 265010 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Potent B-Raf inhibitor

Potent B-Raf inhibitor (Kd = 0.3 nM). Selective for B-Raf against 46 other kinases (Ki app values are 0.16 and 1.72 nM for B-Raf and c-Raf respectively). Decreases anchorage-independent growth of melanoma cell lines. Inhibits ERK phosphorylation and proliferation in tumor cells expressing B-RafV600E.

Chemical Identifiers

CAS 405554-55-4
Molecular Formula C27H27N5O2
Molecular Weight (g/mol) 453.55
MDL Number MFCD16038645
InChI Key DPCXEUSDRQOOGZ-UHFFFAOYSA-N
Synonym 5-2-4-2-dimethylamino ethoxy phenyl-5-4-pyridinyl-1h-imidazol-4-yl-2,3-dihydro-1h-inden-1-one oxime, 2-4-4-1e-1-hydroxyimino-2,3-dihydroinden-5-yl-5-pyridin-4-yl-1h-imidazol-2-yl phenoxy ethyl dimethylamine, 2-4-4-1z-1-hydroxyimino-2,3-dihydroinden-5-yl-5-pyridin-4-yl-1h-imidazol-2-yl phenoxy ethyl dimethylamine, 2-4-4-1-hydroxyimino-2,3-dihydroinden-5-yl-5-pyridin-4-yl-1h-imidazol-2-yl phenoxy ethyl dimethylamine
PubChem CID 53239990
IUPAC Name (2-{4-[5-(1,4-dihydropyridin-4-ylidene)-4-(3-nitroso-2,6-dihydro-1H-inden-6-ylidene)-4,5-dihydro-1H-imidazol-2-yl]phenoxy}ethyl)dimethylamine
SMILES CN(C)CCOC1=CC=C(C=C1)C1=NC(C(N1)=C1C=CNC=C1)=C1C=CC2=C(CCC2=C1)N=O

Specifications

Quantity 10 mg
Formula Weight 453.54
Percent Purity >98%
Chemical Name or Material SB 590885
Recommended Storage Store at -20°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.